Class Claims Ballard Overhyped Electric Bus Project in China

Shareholders claim in a class action that fuel-cell maker Ballard Power Systems overstated the number of its electric buses operational in China and misled investors about the viability of future business opportunities, causing its share price to fall 20 percent on the news.

Read more

Funko Inc. Sued After Post-IPO Drop in Stock Price Due to Funky Accounting Practices

After raising more than $100 million in its initial public offering, pop culture product maker Funko Inc. is being sued for allegedly filing misleading registration statements with the Securities Exchange Commission in connection with its IPO.

Read more

Class Claims Tersaro Stock Plunged After Revealing Cancer Drug’s Risks

Shareholders of biopharmaceutical company Tesaro Inc. claim in a class action that the company covered up health risks associated with a cancer drug until forced by the U.S. Food and Drug Administration to report the drug’s serious adverse effects.

Read more

Iovance Failed to Disclose Paid Shills Promoting its Stock, Class Claims

Investors claim they were misled when Iovance Biotherapeutics covertly paid a promoter to write articles and send emails pushing its stock until the Securities Exchange Commission stepped in with a cease-and-desist order.

Read more

Investors Claim Info Lacking on Cisco’s Bid for BroadSoft

A shareholder class action in Maryland demands revisions to the proxy statement for Cisco’s pending $1.9 billion buyout of business-communication firm BroadSoft because the document allegedly lacks key financial projections and an explanation of its discounted cash-flow analyses.

Read more

Derivative Action Against Depomed as Senate Investigates Opioid Industry Practices

One of the top manufacturers of prescription opioids in the United States is being called out by investors for the company’s alleged role in fuelling the opioid epidemic, which launched a senate investigation and a one-day plummet in the company’s share price.

Read more